Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 94Genitourinary 56Sarcoma 19Gastrointestinal 17Breast 15Thoracic 5Head & Neck 4CNS 4Tumor-Agnostic 3Other solid neoplasm 3Dermatologic 3Classical hematology 2Other neoplasm 1Other 1

Conditions

Uveal Melanoma 2Melanoma 2Uveitis 1Prostatic Neoplasms 1Lung Neoplasms 1Choroid Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Brachytherapy × Dermatologic × Clear all
NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation
10 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT01777802 2025-08-27

SBRT

Mayo Clinic

Completed
98 enrolled
BreastDermatologicGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms

NCT00000124 2006-06-02

Collaborative Ocular Melanoma Study (COMS)

National Eye Institute (NEI)

Phase 3 Unknown
Dermatologic

Uveal Melanoma, Choroid Neoplasms, Uveitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡